Automated stress echocardiography analysis; EchoGo Heart Failure holds FDA Breakthrough Device status.
Multiple FDA clearances, including Breakthrough Device status for EchoGo Heart Failure.
Vendor-published study summary.
Published study describing improved diagnostic accuracy of stress echocardiography across SIX named NHS hospitals — a relatively strong, multi-site deployment claim for this scan.
Multi-site NHS deployment (six named hospitals) with a published accuracy-improvement study.
Confirm the independence of the cited study (author affiliations, funding) before presenting it as fully independent evidence.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.
Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.